Picture of Novacyt SA logo

ALNOV Novacyt SA Cashflow Statement

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Annual cashflow statement for Novacyt SA, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

C2021
December 31st
2022
December 31st
C2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-9.73-25.7-28.3-41.8
Depreciation
Non-Cash Items-0.2132.42-1.42-0.272
Unusual Items
Other Non-Cash Items
Changes in Working Capital17.71.66-5.3832.2-9.21
Change in Accounts Receivable
Change in Inventories
Change in Payable / Accrued Expenses
Other Operating Cash Flow
Cash from Operating Activities15.7-13.7-25.4-9.82-9.21
Capital Expenditures-4.1-0.416-0.671-1.86-0.881
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-0.887-0.161-13.30.0010.7
Acquisition of Business
Sale of Fixed Assets
Other Investing Cash Flow
Cash from Investing Activities-4.99-0.577-13.9-1.86-0.181
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-0.639-0.516-3.51-1.84-1.95
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash9.98-14.8-42.9-13.6-11.3